AMVUTTRA® (vutrisiran) Treats adults with transthyretin amyloidosis cardiomyopathy or hereditary transthyretin amyloidosis polyneuropathy through an approved RNAi medicine that reduces transthyretin production.
Visit productCosigns Received
Be the first Cosign
Put your name behind AMVUTTRA® (vutrisiran).
Add it to your Products I use list and share why you use it.